Navigation Links
Sugars Could Contain Key Cancer Inhibiting Compounds

An Association for International Cancer Research team has come out with the startling finding that a natural compound found in glucose blocks the development of tumors in mice. This discovery could be vital in fighting cancer and // related illnesses.

The sugar molecules work by blocking the hormones that are essential for the growth of blood vessels in the tumor. In effect they strangle the tumor by blocking blood and nutrient supply to it. Cancer experts are now looking at sugar to halt the growth of tumors before they get out of hand and metastasize causing serious harm. The Clinical Cancer Research journal reports that this technique uses a complex natural sugar called heparin. "If someone has cancer, it has often spread so what you may find is that this treatment could be used once the initial tumor has been removed. It could be used to stop the cancer cells developing when they have spread. But we will have to see how it develops in future trials," said Dr Mark Matfield, scientific consultant of Association for International Cancer Research.

This sugar treatment is effective only in reducing tumor size when it is detected early, but researchers are hopeful of finding ways to integrate this treatment into the normal cancer therapy. Lead researcher Professor Gordon Jayson, of the Manchester's Christie's Hospital was confident that they could begin clinical trials in two years' time. Dr Kat Arney, science information officer at Cancer Research UK said that the research had exciting potential and could point the way to future cancer treatments, "Because adults don't normally need to grow new blood vessels, this discovery could lead to a highly specific and effective treatment for many types of cancer. However, this research is still at an early stage and it will be essential to develop these sugars further and test their actions in patients," she commented.
'"/>




Page: 1

Related medicine news :

1. Sugars in Liver Found to Clear Fats from the Bloodstream
2. Lean Protein Could Be Key to Obesity Drugs
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Nasal Spray Could Take Drugs Directly to Brain
5. Oxygen Usage During Exercise Could Indicate Heart Problems
6. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
7. Anger Could Be Linked To Weight Gain
8. A Seizure Late In Life Could be A Stroke Warning
9. New Findings Could Reduce The Extent Of Spinal Cord Injuries
10. Could There Be A Link Between Famine and Breast Cancer ?
11. Bone Marrow Cells Could Yield A New Lease of Life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on his ... the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his family ... hospital’s 30th heart transplant recipient. , “He was playing at home, when we got ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... One ... regular changing of the securement tape is painful for her. "This is why the ... to patients’ heads," she said. , They then created a prototype of the patent-pending ...
(Date:12/7/2016)... ... December 07, 2016 , ... The Honolulu cosmetic and ... website, which launched October 17, 2016, features comprehensive information regarding a wide range ... Visitors and patients can discover the latest clinical dermatology treatments for medical skin ...
(Date:12/7/2016)... ... , ... The medical profession is well aware that heart attacks do indeed ... heart attacks among 138,602 people recorded a 35% higher number of heart attacks in ... of course–no time of year is a good time for a heart attack! In ...
(Date:12/7/2016)... ... December 07, 2016 , ... “The Road To Restoration”: ... trial, not a one hour a week showing of hands. “The Road To Restoration” ... begins, “Perhaps you are familiar with the brass ring that you could reach out ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 2016   Arena Pharmaceuticals, Inc. (NASDAQ: ... enrollment in the ralinepag phase 2 trial.  Ralinepag is ... pathway for the treatment of pulmonary arterial hypertension (PAH). ... "This marks an important step in the ... focus on our pipeline," said Amit Munshi , ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 According to ... in more than one-third (38%) of patients with non-small cell ... epidermal growth factor receptor (EGFR) genetic mutation status. The findings ... ( LBA ID #6067 #P3.02b ) at the ... Vienna, Austria . The survey results revealed ...
(Date:12/7/2016)... 7,2016  Based on its recent analysis ... & Sullivan recognizes Nemaura Pharma Limited with ... for Enabling Technology Leadership. Nemaura Pharma,s transdermal ... traditional drug delivery technologies, especially in delivering ... delivery technologies, Memspatch and Micropatch respectively, facilitate ...
Breaking Medicine Technology: